STAMFORD, Conn., July 19, 2018 /PRNewswire/ — (Booth 106) — FUJIFILM Medical Systems U.S.A., Inc., a leading provider of Enterprise Imaging and Informatics solutions, will demonstrate Synapse® Cardiovascular, its comprehensive enterprise solution for cardiology, at the World Society for Pediatric and Congenital Heart Surgery’s (WSPCHS) 6thscientific meeting. This meeting is the premier gathering of the largest professional organization in the world dedicated to pediatric and congenital cardiac surgery. It will take place in Walt Disney World in Orlando, Florida, from July 23 – 26, 2018.
“Fujifilm supports the World Society for Pediatric and Congenital Heart Surgery’s goal of promoting the highest quality comprehensive cardiac care to patients with congenital heart disease, from the fetus to the adult,” said Bill Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems U.S.A., Inc. “Leveraging our broad experience with our pediatric provider partners we bring a holistic approach to Enterprise Imaging for Children’s hospitals. Fujifilm’s Synapse Cardiovascular features diagnostic capabilities for image analysis and structured clinical reporting across the continuum of care; supporting enhanced imaging access for fetal, pediatric, and adult congenital heart conditions.”
Fujifilm launched its comprehensive pediatrics portfolio at RSNA 2017, complete with solutions across multiple modalities including digital radiography, healthcare IT and point-of-care ultrasound. The company’s pediatric suite of imaging solutions addresses challenges of pediatric imaging by ensuring safety, advanced precision, enhanced comfort and trusted protection of data.
At WSPCHS, Fujifilm will exhibit Synapse Cardiovascular. Developed with direction from cardiologists, Synapse Cardiovascular offers capabilities and tools that help streamline workflow, image review, and reporting for a variety of cardiac areas.
Synapse Cardiovascular provides a comprehensive enterprise solution, with workflow modules across the cardiovascular service line. Diagnostic capabilities for image analysis and structured clinical reporting are available for echocardiography (adult, pediatric, fetal, and stress), cardiac catheterization, invasive peripheral vascular, noninvasive vascular, nuclear cardiology, cardiac CT/MR, and ECG management.
With extensive single-click measurement capabilities, Synapse Cardiovascular boosts echo lab workflows and facilitates accurate analysis. Flexible measurement options include pediatric Z-scores, preset measurement routines for 2D and M-mode, user-defined measurements and calculations, show points to link to image where measurement was performed, and more than 400 ASE-suggested default cardiac measurements and calculations are available for off-line analysis.
Visit Fujifilm at booth #106 to learn more and for a product demonstration.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujifilmhealthcare.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation in Tokyo, Japan, brings innovative solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies derived from photographic film. Its proprietary core technologies contribute to the fields of healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
SOURCE FUJIFILM Medical Systems U.S.A., Inc.